CorMedix Inc. Reports Second Quarter and Six Month 2022 Financial Results and Provides Business Update
August 11, 2022 07:30 ET
|
CorMedix, Inc.
BERKELEY HEIGHTS, N.J., Aug. 11, 2022 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention...
CorMedix Inc. Announces Regulatory and Manufacturing Updates
August 08, 2022 16:05 ET
|
CorMedix, Inc.
BERKELEY HEIGHTS, N.J., Aug. 08, 2022 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention...
CorMedix Inc. To Report Second Quarter 2022 Financial Results and Provide a Corporate Update on August 11
August 01, 2022 08:30 ET
|
CorMedix, Inc.
BERKELEY HEIGHTS, N.J., Aug. 01, 2022 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention...
CorMedix to Participate at the JMP Securities Life Sciences Conference
June 08, 2022 08:30 ET
|
CorMedix, Inc.
BERKELEY HEIGHTS, N.J., June 08, 2022 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention...
CorMedix Inc. Reports First Quarter 2022 Financial Results and Provides Business Update
May 12, 2022 16:01 ET
|
CorMedix, Inc.
BERKELEY HEIGHTS, N.J., May 12, 2022 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention...
CorMedix Inc. Announces Leadership Updates and Operational Changes
May 12, 2022 08:30 ET
|
CorMedix, Inc.
BERKELEY HEIGHTS, N.J., May 12, 2022 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention...
CorMedix Inc. to Report First Quarter 2022 Financial Results and Provide a Corporate Update on May 12
May 03, 2022 08:30 ET
|
CorMedix, Inc.
BERKELEY HEIGHTS, N.J. , May 03, 2022 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention...
CorMedix Inc. Announces Scientific Advisory Board to Support Commercialization and Pipeline Development
April 07, 2022 08:30 ET
|
CorMedix, Inc.
BERKELEY HEIGHTS, N.J., April 07, 2022 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention...
CorMedix Inc. to Present at the 21st Annual Needham Virtual Healthcare Conference
April 04, 2022 08:30 ET
|
CorMedix, Inc.
BERKELEY HEIGHTS, N.J., April 04, 2022 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention...
CorMedix Inc. Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update
March 29, 2022 16:01 ET
|
CorMedix, Inc.
BERKELEY HEIGHTS, N.J., March 29, 2022 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention...